Floximed 3 mg/g unguent oftalmic Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

floximed 3 mg/g unguent oftalmic

world medicine ophthalmics limited - ciprofloxacinum - unguent oftalmic - 3 mg/g

MEROPENEM ACCORD 1 g Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

meropenem accord 1 g

accord healthcare limited - marea britanie - meropenemum - pulb. pt. sol. inj./perf. - 1g - alte antibiotice betalactamice carbapeneme

MEROPENEM ACCORD 500 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

meropenem accord 500 mg

accord healthcare limited - marea britanie - meropenemum - pulb. pt. sol. inj./perf. - 500mg - alte antibiotice betalactamice carbapeneme

MEROPENEM AUROBINDO 1 g Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

meropenem aurobindo 1 g

apl swift services (malta) limited - malta - meropenemum - pulb. pt. sol. inj./perf.  - 1g - alte antibiotice betalactamice carbapeneme

MEROPENEM AUROBINDO 500 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

meropenem aurobindo 500 mg

apl swift services (malta) limited - malta - meropenemum - pulb. pt. sol. inj./perf. - 500mg - alte antibiotice betalactamice carbapeneme

ERTAPENEM AUROBINDO 1 g Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ertapenem aurobindo 1 g

apl swift services (malta) limited - malta - ertapenemum - pulb. pt. conc. pt. sol. perf. - 1g - alte antibiotice betalactamice carbapeneme

Comirnaty Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

TAVANIC 250 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

tavanic 250 mg

opella healthcare international sas - germania - levofloxacinum - compr. film. - 250mg - chinolone antibacteriene fluorochinolone

TAVANIC 500 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

tavanic 500 mg

opella healthcare international sas - germania - levofloxacinum - compr. film. - 500mg - chinolone antibacteriene fluorochinolone

TAVANIC I.V. 250 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

tavanic i.v. 250 mg

sanofi-aventis deutschland gmbh - germania - levofloxacinum - sol. perf. - 5mg/ml - chinolone antibacteriene fluorochinolone